跳转至内容
Merck
CN

主要文件

查看所有文档

O3632

Osteocalcin Fragment 7-19 human

≥97% (HPLC)

别名:

Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Glu-Pro-Arg

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:
C65H98N16O19
化学文摘社编号:
120944-72-1
分子量:
1407.57
UNSPSC Code:
12352200
PubChem Substance ID:
24897982
MDL number:
MFCD00133727
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

assay

≥97% (HPLC)

UniProt accession no.

P02818

storage temp.

−20°C

SMILES string

CC(C)CC(NC(=O)C1CCCN1C(=O)C(CC(O)=O)NC(=O)C2CCCN2C(=O)C(Cc3ccc(O)cc3)NC(=O)C4CCCN4C(=O)C(NC(=O)C5CCCN5C(=O)C(C)NC(=O)CN)C(C)C)C(=O)NC(CCC(O)=O)C(=O)N6CCCC6C(=O)NC(CCCNC(N)=N)C(O)=O

InChI

1S/C65H98N16O19/c1-34(2)30-41(53(88)71-39(22-23-50(84)85)60(95)78-26-8-13-44(78)54(89)72-40(64(99)100)12-6-24-69-65(67)68)73-55(90)45-14-9-28-80(45)62(97)43(32-51(86)87)75-56(91)46-15-10-27-79(46)61(96)42(31-37-18-20-38(82)21-19-37)74-57(92)47-16-11-29-81(47)63(98)52(35(3)4)76-58(93)48-17-7-25-77(48)59(94)36(5)70-49(83)33-66/h18-21,34-36,39-48,52,82H,6-17,22-33,66H2,1-5H3,(H,70,83)(H,71,88)(H,72,89)(H,73,90)(H,74,92)(H,75,91)(H,76,93)(H,84,85)(H,86,87)(H,99,100)(H4,67,68,69)

InChI key

XEVUUFOXAJNOGZ-UHFFFAOYSA-N

Gene Information

human ... BGLAP(632)

Other Notes

Calcium-binding protein fragment.

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

新产品

此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
061K51183
072H58163
072H58162
071K11491
061K5118

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

P V Hauschka
Haemostasis, 16(3-4), 258-272 (1986-01-01)
Osteocalcin is an abundant Ca2+-binding protein indigenous to the organic matrix of bone, dentin, and possibly other mineralized tissues. This protein contains 47-50 amino acid residues (molecular weight 5,200-5,900) depending on the species. Osteocalcin is distinguished by its content of
P Pastoureau et al.
Clinical chemistry, 36(9), 1620-1624 (1990-09-01)
Most RIAs of serum bone gla-protein (BGP; also called osteocalcin) used for clinical investigation are based on bovine BGP for standard, tracer, and immunogen because of the homology between bovine and human BGP. However, ovine BGP differs from human BGP
H Jüppner et al.
Calcified tissue international, 39(5), 310-315 (1986-11-01)
Radioiodination of synthetic human 37-49 osteocalcin requires optimal labeling conditions in order to obtain a maximum of mono- and di-iodinated tracer with little contamination by tri- and tetra-iodinated products or "radio-damage." The antibody raised against osteocalcin(h37-49) had the highest affinity